What were the most popular posts on Healthcare Economist this year? Here are the top 10 in descending order: Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best PracticesThe world is relying on the United States to get value-based drug pricing rightWhy is the market design for innovative…
Kaiser Permanente Ventures, Texas Medical Center Venture Fund, Yale New Haven Health join General Catalyst in $10.5 million funding round
Like many Americans who voted for Donald Trump, Jason Rouse hopes the president’s return will mean lower prices for gas, groceries, and other essentials. But Rouse is looking to the federal government for relief from one particular pain point: high health care costs. “The prices are just ridiculous,” said Rouse, 53, a retired Michigan firefighter…
[Sponsored] The webinar, scheduled for May 22, will include executives from PurpleLab and feature Genentech Principal Informatics Systems Lead Dr. Ben Freiberg. Register today! The post Eliminating Blind Spots in the Patient Journey appeared first on MedCity News.
Ambience Healthcare closed a $243 million Series C funding round, bringing its valuation to $1.25 billion. The startup, which offers an AI-powered platform for clinical documentation and coding, aims to reduce clinician burnout by automating time-consuming administrative tasks across a wide range of specialties. The post Ambience Healthcare Gains Unicorn Status & Snags $243M appeared…
RAPID CITY, S.D. — Native American tribes and health organizations are responding to concerns about low measles vaccination rates and patients’ difficulty getting care as an outbreak of the disease spreads around the country. They’re hosting mobile vaccine clinics, running social media campaigns, making sure health providers are vaccinated, reaching out to the parents of…
CMS Innovation Center leading the way on including patient-reported measures in payment models
Durante su primer gobierno, los principales funcionarios de salud del presidente Donald Trump autorizaron a Carolina del Norte a utilizar dinero de Medicaid para servicios sociales que tradicionalmente no estaban cubiertos por el seguro médico. Fue un experimento pionero en el país para canalizar fondos de atención médica hacia vivienda, nutrición y otros servicios sociales….
It seems like the answer is now ‘yes’. EndPoints reports: Stealth BioTherapeutics said the FDA would not meet its Tuesday deadline for approving or rejecting the company’s drug, elamipretide. It had been seeking regulatory clearance of elamipretide for a rare disease called Barth syndrome, which affects only about 150 people in the US and causes…
Three-quarters of U.S. providers and payers say they have increased their IT spending over the past year, according to a new report from Bain & Company and KLAS Research. Both providers and payers are investing in cybersecurity technology, as well as AI tools. The post Providers and Payers Are Increasing Their Tech Spend — Where…